Lecture 19 - drug interactions Flashcards

1
Q

describe what a drug interaction is and the properties of a drug interaction.

A

a drug interaction is a pharmacological or clinical response to the administration of a drug combination differs from the known effects of the two agents when given alone.

object drug is the drug affected by the interaction and precipitant drug is the drug causing the interaction

it may be harmful causing toxicity and reduced efficacy or may be beneficial causing synergistic combinations, increased convenience, reduced toxicity and cost reduction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are the causes of drug-drug interactions ?

A

True incidence difficult to determine
Data for drug-related hospital admissions do not separate out drug interactions, focus on adverse drug reactions

Most data are in the form of case reports

Patients receiving polypharmacy are at risk

Difficulty in assessing role of OTC and herbal drugs in drug interactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are two types of drug drug interactions?

A

pharmacokinetics is when one drug alters the level of another

and pharmacodynamic when there is no change in drug level. Activity of one drug is altered by another

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

describe the pharmacokinetics of how a drug is metabolised in the body

A
  1. site of absorption - drug absorbed into bloodstream by the GI tract
  2. Plasma protein binding - After absorption, the drug can bind to plasma proteins in the blood
  3. Site of metabolism: The liver is often the main site where drugs are metabolized or broken down into different chemicals
  4. Site of action: The drug reaches its target location in the body where it will exert its intended effect.
  5. Site of excretion/reabsorption: Finally, the drug or its metabolites are excreted from the body, commonly through the kidneys into the urine, or through the bile into the feces.

the free drug interacts with different sites of action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

describe the pharmacokinetic interactions at the gastrointestinal tract

A

GI is the site of drug absorption.

Tetracycline can form insoluble complexes with metal ions such as iron, aluminium, and calcium.
As a result of these interactions, there is a loss of therapeutic effect of tetracycline,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what sit he interaction between quinolone antibiotics and antacids

A

there is alteration in absorption known which causes a process known as chelation.

Therefore, it sir recommended of the cheating drug such as antacids to be taken 4 hours before the antibiotics or 2 hours afters the antibiotic dose.

the graph indicates indicates that the absorption of moxifloxacin is significantly reduced when administered with Maalox

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is a drug drug interaction affecting adsorption

A

colestyramine which is a cholesterol reducing agent binds t warfarin, thyroxin and digoxin, causing reduced absorption and therapeutic effect.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

how can stomach pH alter the absorption of a drug?

A

stomach pH can alter the absorption of the drug ketoconazole when taken with antacids or H2 antagonists

Ketoconazole absorption is pH dependent with highest absorption at low gastric pH

the dissolution of ketoconazole is decreased at pH>5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

how can certain drugs can affect the absorption of other medications by altering gastrointestinal (GI) motility?

A

drugs increasing gastric emptying such as metoclopramide and domperidone decreases time for dissolution and absorption of drugs in the stomach eg digoxin and can lead to increased absorption of drug normally absorbed from the small intestine eg ciclosporin

nversely, drugs that decrease gastric emptying, such as opioid analgesics (e.g., morphine) and anticholinergics, can slow down GI motility, potentially leading to a decreased absorption of other drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is the drug interaction between digoxin ad quinidine ?

A

digoxin is sued of heart failure and quinidine for antiarrhythmics

Both medications bind to proteins within the body, but when used together, quinidine can displace digoxin from its protein binding sites. This displacement can lead to an increase in the levels of free digoxin in the bloodstream, as a result there can be increase in digoxin toxicity which manifests as arrhythmias, visual disturbances or Gi disturbances

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

outline the importance of hepatic metbaolism in the liver

A

Numerous drugs are enzymatically metabolised in the liver:
Phase 1 Metabolism
Oxidation
Reduction
Hydrolysis

cytochrome P450 groups; oxidation of drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is the cytochrome P450 system ?

A

groups of enzymes that modify some drugs -substrates, can be turned off - act as inhibitors or can be enhanced ie inducers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

discuss the metabolism of drugs by the CYP450 enzymes

A

Some drugs are metabolized by a single isozyme of CYP450. Examples include:
Desipramine metabolized by CYP2D6
Omeprazole metabolized by CYP2C19
Diclofenac metabolized by CYP2C19

Most drugs are metabolised by more than one isozyme e.g. imipramine (CYP2D6, CYP1A2, CYP2C19)
If co-administered with CYP450 inhibitor, some isozymes may compensate for inhibited isozyme

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are the substates and inhibitors of the CYP2C9 family?

A

substrates are sulfonylureas and S-warfarin

inhibitors are sulfamethoxazole, amiodarone, cimetidine, fluoxetine and fluxconazole

patients administered co-trimoxazole and sulfonylureas were 8 time more likely hospitalised due to hypoglycaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

discuss the concept and of CYP450 induction

A

Inducers are a list of drugs that can increase cyp450 enzymes activity. such as rifampicin, carbamazepine, phenobarbital, phenytoin, nevirapine, pioglitazone and st johns wort.

The induction process has a gradual onset and offset because it involves increased DNA transcription and the synthesis of new CYP enzymes

Onset and offset
(Depends on t1/2 of inducer, time to make new CYP proteins, and rate of degradation of CYP proteins)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what does CYP450 induction result in?

A

Results in reduction of plasma concentration of substrate drugs
Risk of therapeutic failure
Induction may lead to formation of toxic metabolite
Removal of inducer may lead to toxic concentrations of substrate

carbamazepine reduces serum cocnetratiosn of simvastatin nd simvastatin acid. Carbamazepine induces CYP450 isozymes
Simvastatin is metabolised by CYP3A4

17
Q

what are Enzyme inhibitors are used in combination with certain drugs to increase their efficacy?

A

in the treatment of Parkinson’s disease, levodopa is administered to increase dopamine levels in the brain.

Peripheral decarboxylase inhibitors, such as carbidopa and benserazide, are used with levodopa to prevent its conversion to dopamine in the periphery.

This combination aims to Increase central concentration of dopamine,
Decrease peripheral concentration of dopamine, and Reduced dose of levodopa by 10-fold

18
Q

describe P-Glycoprotein

A

A membrane glycoprotein that functions as an ATP-binding cassette (ABC) drug efflux transporter.

It is expressed in various tissues including the intestine, kidney, bile canaliculi, and blood-brain barrier.

P-Glycoprotein serves as a “natural defense mechanism” by pumping foreign substances out of cells, which can affect the absorption and distribution of drugs.

19
Q

what are substrates, inducers and inhibitors of P glycoproteins

A

Substrates: Drugs like digoxin, diltiazem, ciclosporin, and dabigatran etexilate are listed as substrates for P-Glycoprotein, meaning they are transported by this protein.

Inhibitors: The slide lists macrolides, amiodarone, quinidine, antifungals, and verapamil as inhibitors of P-Glycoprotein. These drugs can block the transport function of P-Glycoprotein.

Inducers: Rifampicin, dexamethasone, and St John’s wort are noted as inducers. These substances can increase the activity of P-Glycoprotein, which may lead to decreased concentrations of substrate drugs

20
Q

digoxin vs clarithromycin toxicity

A

clarithromycin inhibits P glycoproteins in the intestine and kidney. bioavailability is increased and renal clearance is decreased.

Patients prescribed clarithromycin whilst taking digoxin were ~15 times more likely to be hospitalised with digoxin toxicity

21
Q

describe classical competitive antagonism

A

Non-selective β antagonists can negate the effects of β2 agonists

ace inhibitor and CCB causes marked hypotension

SSRI and MAO inhibitors used as antidepressants can cause severe SNS stimulation of delirium

amino glycoside antibiotics and loop diuretics can cause ototoxicity ear posing causing hearing and balance impaired